Monitor for any future conversion of this 13G to a 13D, which would signal activist intent. For now, the passive nature and venture capital profile suggest a long-term investment hold rather than near-term catalyst.
Price Chart
Executive Summary
LSP 7 Cooperatief U.A., a Netherlands-based venture capital firm (EQT Life Sciences), disclosed a 6.0% passive stake in Electra Therapeutics, Inc. via Schedule 13G, representing 3,795,281 shares of common stock as of September 21, 2026. The filing certifies no intent to influence or change control of the issuer, making this a routine passive ownership disclosure.
Key Financial Metrics
Key Facts
- LSP 7 Cooperatief U.A. filed Schedule 13G disclosing beneficial ownership of 3,795,281 shares of Electra Therapeutics common stock.
- The stake represents 6.0% of shares outstanding, based on 62,766,955 shares outstanding as of September 21, 2026.
- LSP 7 Management B.V. is the sole director of LSP 7; managing directors Merijn Klaassen, Rene Kuijten, and Joachim Rothe may be deemed beneficial owners but disclaim such ownership.
- The filing certifies the securities were not acquired with the purpose of changing or influencing control of the issuer.
- The investor is a Netherlands-based venture capital firm operating under EQT Life Sciences.
Financial Impact
Passive 6.0% stake in Electra Therapeutics; no transaction price or dollar value disclosed in the filing.
Risk Factors
- Passive 13G filers may convert to activist 13D if conditions change, introducing governance pressure.
- Venture capital investors often seek liquidity events (M&A or IPO follow-on), which could create overhang.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0001193125-26-405752 |
| Document: 0001193125-26-405752-index.html | 0001193125-26-405752 |
| Document: 0001193125-26-405752.txt | 0001193125-26-405752 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 28, 2026 27d ago | SC 13G | $11.35 $11.25 | ▼ −0.88% | ▼ −0.68% | $8.37 (−26.26%) |
Sep 28, 2026 27d ago | SC 13G | $11.35 $11.25 | ▼ −0.88% | ▼ −0.68% | $8.37 (−26.26%) |
Sep 25, 2026 4w ago | SC 13D | $11.32 $11.35 | ▲ +0.27% | ▲ +0.45% | $8.37 (−26.06%) |
Sep 23, 2026 4w ago | Insider Cluster | $11.82 $11.55 | ▼ −2.28% | ▼ −2.83% | $8.37 (−29.19%) |
Sep 21, 2026 4w ago | 3 | $13.62 $12.67 | ▼ −6.97% | ▼ −6.25% | $8.37 (−38.55%) |
Sep 18, 2026 5w ago | 424B4 | $13.92 $13.62 | ▼ −2.16% | ▼ −2.14% | $8.37 (−39.87%) |
Sep 18, 2026 5w ago | 3 | $13.92 $13.62 | ▼ −2.16% | ▼ −2.14% | $8.37 (−39.87%) |
Sep 18, 2026 5w ago | 3 | $13.92 $13.62 | ▼ −2.16% | ▼ −2.14% | $8.37 (−39.87%) |
Sep 18, 2026 5w ago | 3 | $13.92 $13.62 | ▼ −2.16% | ▼ −2.14% | $8.37 (−39.87%) |
Sep 18, 2026 5w ago | EFFECT | $13.25 $13.92 | ▲ +5.06% | ▲ +3.51% | $8.37 (−36.83%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers